Prognosis prediction based on methionine metabolism genes signature in gliomas
Abstract Background Glioma cells have increased intake and metabolism of methionine, which can be monitored with 11 C-L-methionine. However, a short half-life of 11 C (~ 20 min) limits its application in clinical practice. It is necessary to develop a methionine metabolism genes-based prediction mod...
Những tác giả chính: | Sujin Zhou, Xianan Zhao, Shiwei Zhang, Xue Tian, Xuepeng Wang, Yunping Mu, Fanghong Li, Allan Z. Zhao, Zhenggang Zhao |
---|---|
Định dạng: | Bài viết |
Ngôn ngữ: | English |
Được phát hành: |
BMC
2023-12-01
|
Loạt: | BMC Medical Genomics |
Những chủ đề: | |
Truy cập trực tuyến: | https://doi.org/10.1186/s12920-023-01754-x |
Những quyển sách tương tự
-
A prognostic signature based on snoRNA predicts the overall survival of lower-grade glioma patients
Bằng: Yi Zhou, et al.
Được phát hành: (2023-11-01) -
Integrated profiling identifies CACNG3 as a prognostic biomarker for patients with glioma
Bằng: Enfang Shan, et al.
Được phát hành: (2023-09-01) -
Mechanism of CXCL8 regulation of methionine metabolism to promote angiogenesis in gliomas
Bằng: Jie Chang, et al.
Được phát hành: (2024-11-01) -
Comprehensive analysis reveals cholesterol metabolism-related signature for predicting prognosis and guiding individualized treatment of glioma
Bằng: Dengfeng Lu, et al.
Được phát hành: (2025-01-01) -
A novel risk model consisting of nine platelet-related gene signatures for predicting prognosis, immune features and drug sensitivity in glioma
Bằng: Sanlin Wei, et al.
Được phát hành: (2024-12-01)